Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4201 to 4215 of 8905 results

  1. Get involved with HealthTech guidance

    We want you to be involved in our work - whether you’re commenting on our draft recommendations, taking part in guidance development or attending a committee meeting, your voice is important to us.

  2. Selecting and prioritising quality standard topics

    Each year we work with NHSE and the DHSC to prioritise topics for development.

  3. Notify an interventional procedure

    Tell us about an interventional procedure you think should be assessed by NICE.

  4. Prioritisation board decisions 2024

    Our centralised approach to prioritising guidance topics ensures that we produce guidance that is relevant, timely, accessible, and has demonstrable impact.

  5. About evidence summaries

    Summaries of the best available evidence for selected medicines that are considered to be of significance to the NHS.

  6. Antimicrobials evaluation panel members

    Read the biographies for all members of the NICE antimicrobial evaluation committee.

  7. Public health advisory committee F members

    Details about the chair and core members of NICE public health advisory committee F.

  8. Indicator advisory committee members

    Read biographies for all members of NICE's indicator advisory committee.

  9. Contributing to the development of our guidelines

    We've created the guides and resources on this page to help people who are involved in developing NICE guidelines.

  10. Diagnostics advisory committee

    Membership details, terms of reference, future meeting dates and past meeting minutes for our diagnostics advisory committee.

  11. Topic prioritisation

    Find out what guidance is being considered for development

  12. Subscribe to our GP reference panel

    Subscribe to our GP reference panel and contribute to the development of NICE guidance in a quick and easy way.

  13. Key question: effective

    This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.

  14. E‑vita open plus for treating complex aneurysms and dissections of the thoracic aorta (HTG326)

    Evidence-based recommendations on the E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta.

  15. Therapeutic monitoring of TNF-alpha inhibitors in Crohn's disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits) (HTG401)

    Evidence-based recommendations on therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors (LISA-TRACKER, IDKmonitor and Promonitor ELISA kits) in people with Crohn’s disease.